The JCA Subgroup shall discuss the consolidated assessment scope proposal referred to in Article 11(2), as well as the input of individual experts referred to in Article 11(3), during an assessment scope consolidation meeting. The JCA Subgroup, via the HTA secretariat, may invite individual experts to provide their input during a dedicated part of the assessment scope consolidation meeting.
The JCA Subgroup shall finalise the assessment scope at the latest 60 days after the receipt of the information listed in Article 3(1), or 10 days after the adoption of the Commission decision referred to in Article 7(4) of Regulation (EU) 2021/2282 selecting that medical device for joint clinical assessment, whichever is later.
The HTA secretariat shall share the assessment scope finalised by the JCA Subgroup with the health technology developer in the Commission’s first request referred to in Article 10(1) of Regulation (EU) 2021/2282.